BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 35998825)

  • 1. Cancer-associated fibroblasts: Origin, function, imaging, and therapeutic targeting.
    Rimal R; Desai P; Daware R; Hosseinnejad A; Prakash J; Lammers T; Singh S
    Adv Drug Deliv Rev; 2022 Oct; 189():114504. PubMed ID: 35998825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-associated fibroblasts that restrain cancer progression: Hypotheses and perspectives.
    Miyai Y; Esaki N; Takahashi M; Enomoto A
    Cancer Sci; 2020 Apr; 111(4):1047-1057. PubMed ID: 32060987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-Associated Fibroblasts in Conversation with Tumor Cells in Endometrial Cancers: A Partner in Crime.
    Pradip D; Jennifer A; Nandini D
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Versatility of Cancer Associated Fibroblasts: Commendable Targets for Anti-tumor Therapy.
    Khan GJ; Sun L; Khan S; Yuan S; Nongyue H
    Curr Drug Targets; 2018; 19(13):1573-1588. PubMed ID: 29468965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of cancer-associated fibroblast subpopulations in immune infiltration, as a new means of treatment in cancer.
    Mhaidly R; Mechta-Grigoriou F
    Immunol Rev; 2021 Jul; 302(1):259-272. PubMed ID: 34013544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
    Dzobo K; Dandara C
    OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
    Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
    Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription factors in fibroblast plasticity and CAF heterogeneity.
    Melchionna R; Trono P; Di Carlo A; Di Modugno F; Nisticò P
    J Exp Clin Cancer Res; 2023 Dec; 42(1):347. PubMed ID: 38124183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis in the Pancreatic Cancer Tumor Microenvironment-The Double-Edged Sword of Cancer-Associated Fibroblasts.
    Pfeifer E; Burchell JM; Dazzi F; Sarker D; Beatson R
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-associated fibroblasts: Just on the opposite side of antitumour immunity?
    Guo S; Yuan J; Meng X; Feng X; Ma D; Han Y; Li K
    Int Immunopharmacol; 2023 Sep; 122():110601. PubMed ID: 37418988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer associated fibroblast mediated chemoresistance: A paradigm shift in understanding the mechanism of tumor progression.
    Jena BC; Das CK; Bharadwaj D; Mandal M
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188416. PubMed ID: 32822826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional diversity of cancer-associated fibroblasts in modulating drug resistance.
    Bu L; Baba H; Yasuda T; Uchihara T; Ishimoto T
    Cancer Sci; 2020 Oct; 111(10):3468-3477. PubMed ID: 33044028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-associated fibroblasts: Versatile mediators in remodeling the tumor microenvironment.
    Zhang Q; Wang Y; Liu F
    Cell Signal; 2023 Mar; 103():110567. PubMed ID: 36538999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In search of definitions: Cancer-associated fibroblasts and their markers.
    Nurmik M; Ullmann P; Rodriguez F; Haan S; Letellier E
    Int J Cancer; 2020 Feb; 146(4):895-905. PubMed ID: 30734283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Application of Nanoparticles Targeting Cancer-Associated Fibroblasts.
    Huang Q; Ge Y; He Y; Wu J; Tong Y; Shang H; Liu X; Ba X; Xia D; Peng E; Chen Z; Tang K
    Int J Nanomedicine; 2024; 19():3333-3365. PubMed ID: 38617796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploiting the STAT3 Nexus in Cancer-Associated Fibroblasts to Improve Cancer Therapy.
    Allam A; Yakou M; Pang L; Ernst M; Huynh J
    Front Immunol; 2021; 12():767939. PubMed ID: 34858425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-Associated Fibroblasts: Versatile Players in the Tumor Microenvironment.
    Ganguly D; Chandra R; Karalis J; Teke M; Aguilera T; Maddipati R; Wachsmann MB; Ghersi D; Siravegna G; Zeh HJ; Brekken R; Ting DT; Ligorio M
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32957515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancer.
    Bonneau C; Eliès A; Kieffer Y; Bourachot B; Ladoire S; Pelon F; Hequet D; Guinebretière JM; Blanchet C; Vincent-Salomon A; Rouzier R; Mechta-Grigoriou F
    Breast Cancer Res; 2020 Jul; 22(1):76. PubMed ID: 32665033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic Relationship between Cancer-Associated Fibroblasts and Cancer Cells.
    Sazeides C; Le A
    Adv Exp Med Biol; 2018; 1063():149-165. PubMed ID: 29946782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unmasking carcinoma-associated fibroblasts: Key transformation player within the tumor microenvironment.
    Meng Q; Luo X; Chen J; Wang D; Chen E; Zhang W; Zhang G; Zhou W; Xu J; Song Z
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188443. PubMed ID: 33035642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.